BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16125380)

  • 1. A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis.
    Popat S; Houlston RS
    Eur J Cancer; 2005 Sep; 41(14):2060-70. PubMed ID: 16125380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between chromosome 18q status and colorectal cancer prognosis: a prospective, blinded analysis of 280 patients.
    Popat S; Zhao D; Chen Z; Pan H; Shao Y; Chandler I; Houlston RS
    Anticancer Res; 2007; 27(1B):627-33. PubMed ID: 17348452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
    Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
    N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DCC protein and prognosis in colorectal cancer.
    Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC
    N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution analysis of chromosome 18 alterations in ulcerative colitis-related colorectal cancer.
    Terdiman JP; Aust DE; Chang CG; Willenbucher RF; Baretton GB; Waldman FM
    Cancer Genet Cytogenet; 2002 Jul; 136(2):129-37. PubMed ID: 12237237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer.
    Font A; Abad A; Monzó M; Sanchez JJ; Guillot M; Manzano JL; Piñol M; Ojanguren I; Rosell R
    Dis Colon Rectum; 2001 Apr; 44(4):549-57. PubMed ID: 11330582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCC expression and prognosis in colorectal cancer.
    Banerjee AK
    Lancet; 1997 Apr; 349(9057):968. PubMed ID: 9100619
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age.
    Naidoo R; Tarin M; Chetty R
    Am J Gastroenterol; 2000 Nov; 95(11):3266-75. PubMed ID: 11095352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.
    Carethers JM; Hawn MT; Greenson JK; Hitchcock CL; Boland CR
    Gastroenterology; 1998 Jun; 114(6):1188-95. PubMed ID: 9609755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
    Ogunbiyi OA; Goodfellow PJ; Herfarth K; Gagliardi G; Swanson PE; Birnbaum EH; Read TE; Fleshman JW; Kodner IJ; Moley JF
    J Clin Oncol; 1998 Feb; 16(2):427-33. PubMed ID: 9469325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
    Lassus H; Salovaara R; Aaltonen LA; Butzow R
    Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
    Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
    Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer.
    Lanza G; Matteuzzi M; Gafá R; Orvieto E; Maestri I; Santini A; del Senno L
    Int J Cancer; 1998 Aug; 79(4):390-5. PubMed ID: 9699532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.
    Fong KM; Zimmerman PV; Smith PJ
    Cancer Res; 1995 Jan; 55(2):220-3. PubMed ID: 7812947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of 18q LOH in sporadic colorectal carcinoma.
    Pilozzi E; Ferri M; Onelli MR; Mercantini P; Corigliano N; Duranti E; Dionisi L; Felicioni F; Virgilio E; Ziparo V; Ruco L
    Am Surg; 2011 Jan; 77(1):38-43. PubMed ID: 21396303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
    Kubo H; Miki C; Kusunoki M
    Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
    Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
    Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
    Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
    Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.